Clinical Trial

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Postoperative pain after adenoid and tonsil surgery is significant, with approximately 75% of pediatric patients experiencing severe postoperative pain. Currently, there is a lack of clinical strategies to safely and effectively manage postoperative pain in children undergoing adenoid and tonsil surgery. Dexmedetomidine and esketamine can achieve appropriate sedation levels and alleviate postoperative pain when used in children. Both drugs can be administered intranasally, and their pharmacological effects complement each other, reducing side effects. This study aims to investigate whether intranasal administration of dexmedetomidine-esketamine combination can improve postoperative analgesia in children undergoing adenoid and tonsil surgery.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-10
Trial Details
NCT Number NCT07479602
Lead Sponsor Peking University First Hospital
Conditions Adenotonsillectomy, Children, Intranasal Administration, Dexmedetomidine, Esketamine, Postoperative Pain
Enrollment 160 participants
Start Date 2026-04-07
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-09